VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Post-transplant bendamustine for GvHD prophylaxis in refractory acute leukemia

Ivan Moiseev, MD, PhD, First Saint Petersburg State Medical University, Saint Petersburg, Russia, outlines the use of post-transplant bendamustine for GvHD prophylaxis as evaluated in a dose-escalation study in patients with refractory acute leukemias (NCT02799147). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter